IP Library › Granted Patent US 9,944,725
Granted Patent B2
US 9,944,725 · App. 15/334,814 · Granted Apr 17, 2018

Polymer comprising a plurality of phenothiazine groups and methods of making the same

Inventors: Jiangfeng Fei (Sleepy Hollow, NY); William Chiang (Pennington, NJ); Frank Kerrigan (Wadebridge, GB); Stuart Green (Camelford, GB); Craig Robson (Camelford, GB); Howard Easterfield (Bude, GB)
Assignee: Ascensia Diabetes Care Holdings AG
C08F8/34A61K49/0004C07D279/08C07D279/20C07D417/14C08F8/30C08G59/4007C08G59/4064C08G73/024C08G75/24C12Q1/004G01N27/3272
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,944,725
App. No.
15/334,814
Granted
Apr 17, 2018
Kind
B2
Abstract

A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.

Claims (34)

1. A polymer, comprising the general formula (VII):

and salts thereof;

where n is about 9,

x and y independently are an integer from 1 to 10,000, and

z is an integer from 0 to 10,000.

2. The polymer of claim 1 , wherein the mole fraction of x and y is from 0.05 to 0.9.

3. A method of making the polymer of claim 1 , comprising:

forming the polymer from

poly(diallylmethylamine), and

a mixture of 2-(8-(ω-haloalkyl)-3H-phenothiazin-3-ylideneamino)benzene-1,4-disulfonic acid and 2-(2-(ω-haloalkyl)-3H-phenothiazin-3-ylideneamino)benzene-1,4-disulfonic acid.

4. The method of claim 3 , further comprising:

forming the mixture of 2-(8-(ω-haloalkyl)-3H-phenothiazin-3-ylideneamino)-benzene-1,4-disulfonic acid and 2-(2-(ω-haloalkyl)-3H-phenothiazin-3-ylideneamino)-benzene-1,4-disulfonic acid.

5. The polymer of claim 2 , wherein the mole fraction of x and y is from 0.07 to 0.7.

6. The polymer of claim 5 , wherein the mole fraction of x and y is from 0.1 to 0.5.

7. The polymer of claim 1 , wherein the sum of x, y and z is from 10 to 10,000.

8. The polymer of claim 7 , wherein the sum of x, y and z is from 20 to 1,000.

9. The polymer of claim 1 , wherein x and y independently are an integer from 1 to 70.

10. The polymer of claim 9 , wherein x and y independently are an integer from 2 to 20.

11. The polymer of claim 10 , wherein x and y independently are an integer from 10 to 30.

12. An electrochemical test sensor comprising a working electrode, a counter electrode and a mediator, the mediator including a polymer comprising the general formula (VII):

and salts thereof;

where n is about 9,

x and y independently are an integer from 1 to 10,000, and

z is an integer from 0 to 10,000.

13. The test sensor of claim 12 , wherein the mole fraction of x and y is from 0.05 to 0.9.

14. The test sensor of claim 13 , wherein the mole fraction of x and y is from 0.07 to 0.7.

15. The test sensor of claim 14 , wherein the mole fraction of x and y is from 0.1 to 0.5.

16. The test sensor of claim 12 , wherein the sum of x, y and z is from 10 to 10,000.

17. The test sensor of claim 16 , wherein the sum of x, y and z is from 20 to 1,000.

18. The test sensor of claim 12 , wherein x and y independently are an integer from 1 to 70.

19. The test sensor of claim 18 , wherein x and y independently are an integer from 2 to 20.

20. The test sensor of claim 19 , wherein x and y independently are an integer from 10 to 30.

21. The test sensor of claim 12 further including glucose oxidase.

22. The test sensor of claim 12 further including glucose dehydrogenase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2016
From: FU, JIANGFENG; CHIANG, WILLIAM; KERRIGAN, FRANK; GREEN, STUART; ROBSON, CRAIG; EASTERFIELD, HOWARD
To: BAYER HEALTHCARE LLC
Reel/Frame 040216/0388 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 040216/0499 →
Continuity (5)
Division 14963908 · Dec 9, 2015
Division 14259408 · Apr 23, 2014
Division 13116427 · May 26, 2011
Provisional Application 61349469 · May 28, 2010
Related Publication 20170044276A1 · Feb 16, 2017